Results 51 to 60 of about 24,300 (246)
Medical Complications of Lung Transplantation
Lung transplantation (LT) is now considered as an effective treatment option for end-stage lung diseases that improves the short and long-term survival rates and quality of life.
Moo Suk Park
doaj +1 more source
Acute fibrinous and organising pneumonia (AFOP) is a histopathologic variant of acute lung injury that has been associated with infection and inflammatory disorders and has been reported as a complication of lung transplantation.
Keith Meyer +4 more
doaj +1 more source
Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients [PDF]
Background.: We and others have demonstrated that a low level of donor cell chimerism was present for years after transplantation in tissues and peripheral blood of heart and lung recipients; it was associated, in the latter, with a lower incidence of ...
Abdul S. Rao +34 more
core +1 more source
The Role of Galectins in Chronic Lung Allograft Dysfunction [PDF]
Abstract Background Galectins are proteins that bind β-galactosides such as N-acetyllactosamine present in N-linked and O-linked glycoproteins and that seem to be implicated in inflammatory and immune responses as well as fibrotic mechanisms.
d'Alessandro, Miriana +10 more
openaire +3 more sources
Assay for free secretory component and methods for monitoring organ rejection [PDF]
Methods of monitoring and detecting the early onset of organ injury incident rejection of a organ rejection in an animal are disclosed. The described methods are capable of distinguishing organ rejection injury from other organ tissue damage in the ...
Goldblum, Randall M. +1 more
core +1 more source
Adherence is associated with a favorable outcome after lung transplantation.
Non-adherence to therapy is associated with impaired outcome in solid organ allograft recipients. Outcome data are limited after lung transplantation. In a single-center cohort study, adherence was assessed in 427 patients undergoing lung transplantation
Anna Bertram +6 more
doaj +1 more source
Lung transplantation remains as a primary treatment for end-stage lung diseases. Although remarkable improvement has been achieved due to the immunosuppressive protocols, long-term survival for lung transplant recipients (LTR) is still limited.
María Iglesias-Escudero +14 more
doaj +1 more source
A prospective randomized trial of fk506 versus cyclosporine after human pulmonary transplantation [PDF]
We have conducted a unique prospective randomized study to compare the effect of PK506 and cyclosporine (CsA) as the principal immunosuppressive agents after pulmonary transplantation.
Armitage, JM +11 more
core +1 more source
Human neutrophil peptide in lung chronic allograft dysfunction [PDF]
Our previous case-control study identified human neutrophil peptide (HNP) as a potential biomarker for bronchiolitis obliterans syndrome (BOS) in lung transplant recipients.To prospectively validate HNP as a biomarker for BOS.HNP was measured by ELISA in bronchoalveolar lavage (BAL) fluid in lung transplant recipients.The first HNP measurement after ...
Cavan, Reilly +4 more
openaire +2 more sources
Coronavirus infection and chronic lung allograft dysfunction: a retrospective cohort study
INTRODUCTION: Long-term survival in lung transplant recipients is limited by chronic lung allograft dysfunction, which can be triggered by respiratory tract infections. STUDY AIMS: We investigated the incidence of chronic lung allograft dysfunction in
Lydia Canham +8 more
doaj +1 more source

